Scars form when wounds heal. Most scars flatten and fade over time. Keloids and hypertrophic scars do not cooperate. They grow beyond the wound boundaries, become raised and thick, and cause itching, pain, and cosmetic distress. Standard treatments include steroid injections, silicone sheets, and surgical revision, but recurrence rates remain frustrating. Botox has emerged as an adjunct therapy, reducing the muscle tension that contributes to scar hypertrophy and potentially modifying the scarring process itself.
Scar Biology
Understanding why some scars behave badly explains how Botox might help:
Normal scarring: Wounds trigger inflammation, then fibroblasts deposit collagen to close the gap. Over months, the collagen remodels and the scar softens.
Hypertrophic scars: Excessive collagen is deposited, creating a raised, firm scar. The scar stays within the original wound boundaries and often improves over 1-2 years.
Keloids: Collagen deposition extends beyond the wound boundaries. The scar keeps growing, may never stop, and recurs aggressively after surgical removal. Keloids are more common in people with darker skin tones and have genetic predisposition.
| Feature | Normal Scar | Hypertrophic | Keloid |
|---|---|---|---|
| Boundaries | Within wound | Within wound | Beyond wound |
| Natural history | Fades | May regress | Grows indefinitely |
| Recurrence after surgery | Low | Moderate | High |
| Genetic component | Minimal | Some | Strong |
Tension across wounds contributes to scar hypertrophy. Areas of high tension (chest, shoulders, joints) produce worse scars than low-tension areas. This is why surgeons orient incisions along tension lines when possible.
Tension Reduction Mechanism
Botox reduces scar tension by paralyzing underlying muscles:
When muscles adjacent to a healing wound contract, they pull on the scar. This mechanical stress stimulates fibroblast activity and collagen production. The scar thickens in response to the tension.
By weakening the muscles, Botox removes the pulling force. The scar heals under reduced tension, producing a flatter, softer result.
This mechanism is most relevant for scars overlying muscles:
- Forehead scars: Frontalis contraction pulls on vertical scars
- Glabellar scars: Corrugator activity stresses the area
- Perioral scars: Orbicularis oris movement affects lip scars
- Shoulder/chest scars: Pectoralis and deltoid contribute tension
Scars in areas without underlying muscle activity (shin, scalp, hands) would not benefit from this mechanism.
Direct Effects on Fibroblasts
Beyond tension reduction, laboratory research suggests Botox may directly affect scar cells:
Fibroblast activity: Some studies show Botox reduces fibroblast proliferation and collagen synthesis in culture. If this occurs clinically, it could independently reduce scar formation.
TGF-beta modulation: Transforming growth factor beta drives fibrosis. Botox may reduce TGF-beta expression, decreasing the pro-fibrotic signal.
Inflammatory effects: Botox may modulate the inflammatory response that precedes scarring, potentially steering wound healing toward better outcomes.
These direct effects remain investigational. The clinical evidence is stronger for tension reduction than for direct cellular effects.
Treatment Timing
Prevention is more promising than treatment of established scars:
Perioperative injection: Botox injected at the time of surgery or within 24-72 hours provides early tension reduction during the critical early healing phase. This approach shows the strongest evidence.
Early scar treatment: Injecting developing scars in the first few months may still influence their trajectory.
Established keloids: Less evidence supports treating mature keloids with Botox alone. Combination with steroids or other treatments is more common.
Dosing: Varies by location and muscle mass. Typical doses parallel cosmetic applications for the same area. Forehead scars might receive 10-20 units distributed around the scar; shoulder area might need 30-50 units.
Injection pattern: Surrounding the scar rather than into the scar. The goal is muscle relaxation, not direct scar injection (though some protocols include intralesional injection).
Combination Protocols
Botox rarely serves as sole keloid treatment. Established combination approaches include:
Botox + steroids: The most common combination. Triamcinolone (Kenalog) injected directly into the scar, with Botox injected into surrounding muscle. The steroid addresses existing scar tissue; the Botox reduces tension on the healing injection sites.
Botox + silicone: Silicone sheets or gel applied to the scar surface while Botox relaxes underlying muscle. Non-invasive combination.
Botox + 5-FU: 5-fluorouracil, sometimes used for resistant keloids, combined with Botox for tension reduction.
Botox + surgical revision: For keloids requiring excision, Botox injected at the time of surgery reduces recurrence rates.
Evidence quality: Most combination protocols come from case series and small studies. Rigorous comparison data is limited.
Realistic Outcomes
Patients should understand realistic expectations:
For prevention: Botox during wound healing may produce noticeably better scars in high-risk patients or high-tension areas. The evidence is strongest here.
For hypertrophic scars: Combination treatment can flatten and soften existing scars. Complete normalization is uncommon; improvement is the goal.
For keloids: Even with aggressive treatment, keloids frequently recur. Botox may reduce recurrence rates but does not guarantee success. Patients with strong keloid tendency need long-term management plans.
Cost considerations: Botox for scar prevention or treatment is typically not covered by insurance despite the medical indication. Patients pay out of pocket.
Sources:
- Tension and scarring: Plastic and Reconstructive Surgery, “The Role of Mechanical Forces in Scar Formation”
- Fibroblast effects: Journal of Plastic, Reconstructive & Aesthetic Surgery, “Botulinum Toxin Effects on Keloid Fibroblasts”
- Clinical protocols: Dermatologic Surgery, “Botulinum Toxin for Prevention and Treatment of Hypertrophic Scars”
- Combination therapy: Aesthetic Surgery Journal, “Multimodal Keloid Management”